Screening of active parts of Simiao Yong′an Decoction based on PPAR-γ agonist and analysis its chemical composition
LI Hui1,2 YANG Hui3 BAI Yunqi2 WANG Shuqi1,2 SUN Kehan1,2 GAO Zhao2 LOU Lixia2 WU Aiming2 WU Shengxian2 NIE Bo1,2
1.School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing 100029, China;
2.Key Laboratory of Chinese Internal Medicine of Ministry of Education and Beijing, Dongzhimen Hospital, Beijing University of Chinese Medicine, Beijing 100700, China;
3.Jiangxi Qingfeng Pharmaceutical Co., Ltd (Beijing), Beijing 100027, China
Abstract：Objective To screen the active parts of Simiao Yong′an Decoction with peroxisome proliferators-activated receptor γ (PPAR-γ) activation and analyze its chemical components, and to explore the active components and anti-inflammatory effects of the extract. Methods Eight alcohol extracts of Simiao Yong′an Decoction were obtained by alcohol extraction and resin separation. The PPAR-γ was used as the target to screen the active parts of the extract of Simiao Yong′an Decoction at the cell level. A dose-dependent curve was drawn for the extracts with active tendency. EC50 value and relative activity value were calculated, and the chemical composition of active parts was analyzed and identified by liquid chromatograph-tandem mass spectrometer technology. Results In the PPAR-γ activation model, the extracts CS04 and CS05 have strong PPAR-γ activation. The chemical components of the active parts CS04 and CS05 with strong PPAR-γ agonistic effects were identified. A total of 31 components were identified. Conclusion CS04 and CS05 of Simiao Yong′an Decoction have strong PPAR-γ activation, which may be related to the inhibition of atherosclerosis inflammation.
李慧1,2 杨会3 白云绮2 王淑琪1,2 孙克寒1,2 高照2 娄利霞2 吴爱明2 吴圣贤2 聂波1,2. 基于PPAR-γ激动剂的四妙勇安汤活性部位筛选及其化学成分分析[J]. 中国医药导报, 2020, 17(16): 28-33.
LI Hui1,2 YANG Hui3 BAI Yunqi2 WANG Shuqi1,2 SUN Kehan1,2 GAO Zhao2 LOU Lixia2 WU Aiming2 WU Shengxian2 NIE Bo1,2. Screening of active parts of Simiao Yong′an Decoction based on PPAR-γ agonist and analysis its chemical composition. 中国医药导报, 2020, 17(16): 28-33.
[1] 邓天真.心脑血管疾病的中医辨证治疗[J].当代医学，2013（11）：148-149.
[2] Sun LF，An DQ，Niyazi GL，et al. Effects of Tianxiangdan Granule treatment on atherosclerosis via NF-κB and p38MAPK signaling pathways [J]. Mol Med Rep，2018，17（1）：1642．
[3] Anogeianaki A，Angelucci D，Cianchetti E，et al. Atherosclerosis：a classic inflammatory disease [J]. Int J Immunopathol Pharmacol，2015，24（4）：817-825.
[4] 安毅，宫丽鸿，魏伟超.搜风祛痰法对ApoE基因敲除小鼠主动脉易损斑块炎症反应及PPARγ基因表达的影响[J].中国中医急症，2014，23（9）：1591-1593，1609.
[5] Celinski K，Dworzanski T，Fornal R，et al. Comparison of anti-inflammatory properties of peroxisome proliferator-activated receptor gamma agonists rosiglitazone and troglitazone in prophylactic treatment of experimental colitis [J]. J Physiol Pharmacol，2013，64（5）：587-595.
[6] 隋亚那，朱勤伟.替米沙坦通过激活PPARγ而下调NF-κB通路抑制脂多糖诱导的单核细胞THP-1炎症反应[J].中国动脉硬化杂志，2014，22（12）：1225-1230.
[7] 阮景明，朱鹏立，蒋娜，等.白藜芦醇对兔动脉粥样硬化及PPARγ相关炎症因子表达的影响[J].中国动脉硬化杂志，2013，21（3）：203-208.
[8] 漆仲文，李萌，朱科，等.四妙勇安汤促进滋养血管成熟化稳定动脉粥样硬化易损斑块机制研究[J].中华中医药杂志，2019，34（5）：1998-2001.
[9] 彭立，张军平.四妙勇安汤防治动脉粥样硬化性疾病的临床应用及作用机制研究[J].天津中医药，2009，26（4）：351-352.
[10] 王立茹.四妙勇安汤对急性冠脉综合征患者血清超敏C反应蛋白的影响[J].陕西中医，2010，31（6）：646-647.
[11] Peng L，Li M，Xu YZ，et al. Effect of Si-Miao-Yong-An on the stability of atherosclerotic plaque in a diet-induced rabbit model [J]. J Ethnopharmacol，2012，143（1）：241-248.
[12] 张军平，李明，李良军，等.四妙勇安汤调控核因子-κB活性及抑制相关炎症因子的实验研究[J].中华中医药杂志，2010，25（3）：54-58.
[13] Tan G，Zhu Z，Zhang H，et al. Analysis of phenolic and triterpenoid compounds in licorice and rat plasma by high-performance liquid chromatography diode-array detection，time-of-flight mass spectrometry and quadrupole ion trap mass spectrometry [J]. Rapid Commun Mass Spectrom，2010，24（2）：209-218.
[14] Qi LE，Chen CY，Li P. Structural characterization and identification of iridoid glycosides，saponins，phenolic acids and flavonoids in Flos Lonicerae Japonicae by a fast liquid chromatography method with diode-array detection and time-of-flight mass spectrometry [J]. Rapid Commun Mass Spectrom，2009，23（19）：3227-3242.
[15] Matsuda H，Murakami T，Nishida N，et al. Yoshikawa M. Medicinal foodstuffs. XX. Vasorelaxant active constituents from the roots of Angelica furcijuga Kitagawa：structures of hyuganins A，B，C，and D [J]. Chem Pharm Bull（Tokyo），2000，48（10）：1429-1435.
[16] Dictionary of Natural Products on CD-ROM，The Chapman & Hall/CRC，2006.
[17] 李晓，刘剑刚，刘龙涛，等.中药组分及有效成分干预动脉粥样硬化易损斑块相关信号通路的研究进展[J].中药新药与临床药理，2014，25（2）：231-235.
[18] 韩彩萍，李红莉.过氧化物酶体增殖物激活受体-γ在动脉粥样硬化斑块中的表达和作用[J].上海医学，2014， 37（3）：177，223-226.
[19] 刘森，王丹，蔡国才，等.过氧化物酶体增殖物激活受体β在心血管代谢性疾病中的作用[J].中国医药导报，2018， 15（5）：32-36.
[20] 刘娟，李晓燕.过氧化物酶体增殖物活化受体-γ在血管疾病中的多效性作用[J].中国循证心血管医学杂志，2014，6（5）：645-646.
[21] 吴圣贤，聂波，潘美香，等.解毒活血法对ApoE-/-小鼠动脉粥样硬化斑块PPAR-γ和炎性因子的影响[J].辽宁中医杂志，2014，41（5）：1046-1048.
2020, Vol. 17 
京公网安备 11010502046598号